Skip to Main Content

Author Details

Aruz Mesci
Juravinski Cancer Centre
2006
33
15
PMIDPaper TitleJournal TitlePublished Year
36910062Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer.J Thorac Dis2023
37592085[<sup>18</sup>F]-FDG PET in anal canal cancer: a systematic review and meta-analysis.Eur J Nucl Med Mol Imaging2023
37584455Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α.Mol Oncol2023
37684337The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy.Commun Biol2023
36713978<sup>18</sup>F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer.Clin Transl Radiat Oncol2023
34740548The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments.Clin Genitourin Cancer2022
35481918Current and future strategies for radiation therapy in gastric cancer.J Surg Oncol2022
35170226Salvage radiotherapy following HiFU: An institutional series and literature review.J Med Imaging Radiat Oncol2022
33172830Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study.Radiother Oncol2021
34479029Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses.Transl Oncol2021
34561033Tyrosine Kinase Inhibitor Therapy in Unresectable Locally Advanced NSCLC: Keep Holding Our Breaths or Time to Take a Breather?J Thorac Oncol2021
32054978Publisher Correction: Production of recombinant soluble dimeric C-type lectin-like receptors of rat natural killer cells.Sci Rep2020
30987640RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.J Transl Med2019
31780667Production of recombinant soluble dimeric C-type lectin-like receptors of rat natural killer cells.Sci Rep2019
26976434Breast Cancer Patients' Preferences for Adjuvant Radiotherapy Post Lumpectomy: Whole Breast Irradiation vs. Partial Breast Irradiation-Single Institutional Study.J Cancer Educ2018
30564325Spurious elevation of Prostate-specific antigen associated with shingles in a prostate cancer patient undergoing active surveillance.Clin Case Rep2018
29344552Collagen and Calcium Binding EGF Domains 1 (CCBE1) in cancer - a new role past lymphatics?Oncoscience2017
28340350A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family.Cell2017
28089482Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic review.Radiother Oncol2017
28249544Efficacy of single fraction conventional radiation therapy for painful uncomplicated bone metastases: a systematic review and meta-analysis.Ann Palliat Med2017
28419078Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis.Br J Cancer2017
28288457Interferon-Dependent Induction of Clr-b during Mouse Cytomegalovirus Infection Protects Bystander Cells from Natural Killer Cells via NKR-P1B-Mediated Inhibition.J Innate Immun2017
26044139Modulation of Clr Ligand Expression and NKR-P1 Receptor Function during Murine Cytomegalovirus Infection.J Innate Immun2015
25516649Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.World J Gastroenterol2014
24145350miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1.Cancer Res2013
21701977CELLISA: reporter cell-based immunization and screening of hybridomas specific for cell surface antigens.Methods Mol Biol2011
20823164Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition.Cancer Res2010
18595730Evolution of the Ly49 and Nkrp1 recognition systems.Semin Immunol2008
17240452Recognition of H-2K(b) by Ly49Q suggests a role for class Ia MHC regulation of plasmacytoid dendritic cell function.Mol Immunol2007
17433358A rapid and efficient method for the generation and screening of monoclonal antibodies specific for cell surface antigens.J Immunol Methods2007
17462921Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis.Immunity2007
16751398Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells.J Immunol2006
17003506NKR-P1 biology: from prototype to missing self.Immunol Res2006
  • 1 - 33 of 33

Recommended Authors

Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 2
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 1
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
Alexandra Drakaki
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 2
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 2
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 1
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 1
Sean M McBride
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Felix Y Feng
UCSF Medical Center-Mount Zion
Career Start Year 1997
Number of shared co-authors 6
Phuoc T Tran
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 3
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Career Start Year 1995
Number of shared co-authors 1
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 1
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 6
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 1
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 1
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 1
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 3
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 3
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 6
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 2

Collaborators

Stanley K Liu
Odette Cancer Centre, University of Toronto
Co-authored papers 7
Xiaoyong Huang
Medical College, Yan'an University
Co-authored papers 4
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Co-authored papers 3
Samira Taeb
Sunnybrook Research Institute
Co-authored papers 3
Edward Chow
University of Toronto
Co-authored papers 3
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Hon S Leong
University of Toronto
Co-authored papers 2
Peter Hoskin
Mount Vernon Cancer Centre
Co-authored papers 2
Sahar Jahangiri
Tehran University of Medical Sciences
Co-authored papers 2
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 2
Michelle R Downes
University of Toronto
Co-authored papers 1
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Emmanouil Fokas
Universityhospital Frankfurt
Co-authored papers 1
Michelle Meringer
Sunnybrook Research Institute
Co-authored papers 1
Christianne Hoey
Evaluative Clinical Sciences, Sunnybrook Research Institute
Co-authored papers 1
Robert G Bristow
University of Toronto
Co-authored papers 1
Fabrice Lucien
Mayo Clinic
Co-authored papers 1
Elina Korpela
University of Toronto.
Co-authored papers 1
Urban Emmenegger
Odette Cancer Centre
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Jessica Ray
Sunnybrook Research Institute, University of Toronto
Co-authored papers 1
Rod Bremner
University of Toronto
Co-authored papers 1
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Co-authored papers 1
Enhua Wang
The First Hospital and College of Basic Medical Sciences, China Medical University
Co-authored papers 1
Release 1.2